Engaging Patients in the Canadian Real-World Evidence for Value in Cancer Drugs (CanREValue) Initiative: Processes and Lessons Learned

The Canadian Real-world Evidence for Value in Cancer Drugs (CanREValue) Collaboration established the Engagement Working Group (WG) to ensure that all key stakeholders had an opportunity to provide input into the development and implementation of the CanREValue Real-World Evidence (RWE) Framework. T...

Descripción completa

Detalles Bibliográficos
Autores principales: Evans, William K., Takhar, Pam, McDonald, Valerie, Elias, Martine, Binder, Louise, Michaud, Stéphanie, Tadrous, Mina, Muñoz, Caroline, Chan, Kelvin K. W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406430/
https://www.ncbi.nlm.nih.gov/pubmed/36005181
http://dx.doi.org/10.3390/curroncol29080443

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406430/
https://www.ncbi.nlm.nih.gov/pubmed/36005181
http://dx.doi.org/10.3390/curroncol29080443

Ejemplares similares